During the last session, P3 Health Partners Inc (NASDAQ:PIII)’s traded shares were 0.54 million, with the beta value of the company hitting 0.99. At the end of the trading day, the stock’s price was $0.21, reflecting an intraday loss of -0.93% or -$0.01. The 52-week high for the PIII share is $1.78, that puts it down -747.62 from that peak though still a striking 9.52% gain since the share price plummeted to a 52-week low of $0.19. The company’s market capitalization is $76.43M, and the average intraday trading volume over the past 10 days was 1.21 million shares, and the average trade volume was 771.93K shares over the past three months.
P3 Health Partners Inc (PIII) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.80. PIII has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
P3 Health Partners Inc (NASDAQ:PIII) trade information
P3 Health Partners Inc (PIII) registered a -0.93% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.93% in intraday trading to $0.21, hitting a weekly high. The stock’s 5-day price performance is -6.78%, and it has moved by -51.52% in 30 days. Based on these gigs, the overall price performance for the year is -81.32%. The short interest in P3 Health Partners Inc (NASDAQ:PIII) is 0.96 million shares and it means that shorts have 1.21 day(s) to cover.
P3 Health Partners Inc (PIII) estimates and forecasts
Statistics show that P3 Health Partners Inc has underperformed its competitors in share price, compared to the industry in which it operates. P3 Health Partners Inc (PIII) shares have gone down -63.90% during the last six months, with a year-to-date growth rate less than the industry average at -6.35% against 25.80.
While earnings are projected to return 11.11% in 2024.
PIII Dividends
P3 Health Partners Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
P3 Health Partners Inc (NASDAQ:PIII)’s Major holders
P3 Health Partners Inc insiders own 23.20% of total outstanding shares while institutional holders control 24.99%, with the float percentage being 32.53%. ALYESKA INVESTMENT GROUP, L.P. is the largest shareholder of the company, while 69.0 institutions own stock in it. As of 2024-06-30, the company held over 15.95 million shares (or 13.4152% of all shares), a total value of $7.18 million in shares.
The next largest institutional holding, with 7.9 million shares, is of ARMISTICE CAPITAL, LLC’s that is approximately 6.645% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $3.56 million.
Also, the Mutual Funds coming in first place with the largest holdings of P3 Health Partners Inc (PIII) shares are Columbia Acorn Fund and Vanguard Total Stock Market Index Fund . Data provided on Jun 30, 2024 indicates that Columbia Acorn Fund owns about 5.31 shares. This amounts to just over 3.26 percent of the company’s overall shares, with a $1.13 million market value. The same data shows that the other fund manager holds slightly less at 1.45, or about 0.89% of the stock, which is worth about $0.31 million.
